Arrowhead Pharmaceuticals Stock Performance
| ARWR Stock | USD 23.92 1.59 7.12% |
The firm shows a Beta (market volatility) of 2.36, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Arrowhead Pharmaceuticals will likely underperform. Arrowhead Pharmaceuticals has an expected return of -0.43%. Please make sure to confirm Arrowhead Pharmaceuticals jensen alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if Arrowhead Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in May 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return 7.57 | Five Day Return 0.59 | Year To Date Return (22.54) | Ten Year Return 77.66 | All Time Return (99.18) |
Last Split Factor 1:10 | Last Split Date 2011-11-17 |
1 | Arrowhead Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript | 02/07/2024 |
2 | Northern Trust Corp Sells 31,682 Shares of Arrowhead Pharmaceuticals, Inc. - MarketBeat | 03/07/2024 |
3 | Arrowhead Pharmaceuticals Initiates Phase 12a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy | 03/08/2024 |
4 | 7 Biotech Stocks to Buy as Sector Rotation Ramps Up - InvestorPlace | 03/13/2024 |
5 | Acquisition by Lu Hongbo of 1000 shares of Arrowhead Pharmaceuticals at 28.0 subject to Rule 16b-3 | 03/19/2024 |
6 | ARROWHEAD PHARMACEUTICALS INC. Trade Ideas SWBHDP1 TradingView - TradingView | 03/28/2024 |
7 | Disposition of 6000 shares by Hamilton James C of Arrowhead Pharmaceuticals at 28.03 subject to Rule 16b-3 | 04/01/2024 |
8 | Arrowhead Pharmaceuticals, Inc. Receives Average Recommendation of Moderate Buy from ... - MarketBeat | 04/10/2024 |
| Begin Period Cash Flow | 108 M | |
| Total Cashflows From Investing Activities | -96.2 M |
Arrowhead |
Arrowhead Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 3,281 in Arrowhead Pharmaceuticals on January 24, 2024 and sell it today you would lose (889.00) from holding Arrowhead Pharmaceuticals or give up 27.1% of portfolio value over 90 days. Arrowhead Pharmaceuticals is currently does not generate positive expected returns and assumes 3.9513% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Arrowhead, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Arrowhead Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arrowhead Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Arrowhead Pharmaceuticals, and traders can use it to determine the average amount a Arrowhead Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1093
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARWR |
Estimated Market Risk
| 3.95 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arrowhead Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arrowhead Pharmaceuticals by adding Arrowhead Pharmaceuticals to a well-diversified portfolio.
Arrowhead Pharmaceuticals Fundamentals Growth
Arrowhead Stock prices reflect investors' perceptions of the future prospects and financial health of Arrowhead Pharmaceuticals, and Arrowhead Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arrowhead Stock performance.
| Return On Equity | -1.06 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (1.63) % | ||||
| Operating Margin | (38.45) % | ||||
| Current Valuation | 2.96 B | ||||
| Shares Outstanding | 123.9 M | ||||
| Price To Earning | 482.39 X | ||||
| Price To Book | 19.08 X | ||||
| Price To Sales | 16.84 X | ||||
| Revenue | 240.74 M | ||||
| Gross Profit | 240.74 M | ||||
| EBITDA | (188.16 M) | ||||
| Net Income | (209.28 M) | ||||
| Cash And Equivalents | 416.5 M | ||||
| Cash Per Share | 3.93 X | ||||
| Total Debt | 115.17 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 3.37 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | (153.89 M) | ||||
| Earnings Per Share | (2.77) X | ||||
| Market Capitalization | 2.77 B | ||||
| Total Asset | 765.55 M | ||||
| Retained Earnings | (1.03 B) | ||||
| Working Capital | 110.03 M | ||||
| Current Asset | 90.5 M | ||||
| Current Liabilities | 25.64 M | ||||
About Arrowhead Pharmaceuticals Performance
To evaluate Arrowhead Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Arrowhead Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Arrowhead Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Arrowhead Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Arrowhead's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (681.34) | (647.27) | |
| Return On Tangible Assets | (0.24) | (0.26) | |
| Return On Capital Employed | (0.31) | (0.32) | |
| Return On Assets | (0.24) | (0.25) | |
| Return On Equity | (0.87) | (0.91) |
Things to note about Arrowhead Pharmaceuticals performance evaluation
Checking the ongoing alerts about Arrowhead Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Arrowhead Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Arrowhead Pharmaceuticals generated a negative expected return over the last 90 days | |
| Arrowhead Pharmaceuticals has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 240.74 M. Net Loss for the year was (209.28 M) with profit before overhead, payroll, taxes, and interest of 240.74 M. | |
| Arrowhead Pharmaceuticals currently holds about 416.5 M in cash with (153.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.93. | |
| Arrowhead Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 66.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Arrowhead Pharmaceuticals, Inc. Receives Average Recommendation of Moderate Buy from ... - MarketBeat |
- Analyzing Arrowhead Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arrowhead Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Arrowhead Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arrowhead Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arrowhead Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arrowhead Pharmaceuticals' stock. These opinions can provide insight into Arrowhead Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Arrowhead Stock analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.098 | Earnings Share (2.77) | Revenue Per Share 1.697 | Quarterly Revenue Growth (0.94) | Return On Assets (0.25) |
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.